Table 2. Comparing patient demographics, pain symptoms, past medical history, prior pelvic floor surgery between patients with reported improvement and no improvement in pain after treatment with combined Botox and physical therapy (n=50).
Variable | Pain not improved (n=21) | Pain improved (n=29) | p-value |
---|---|---|---|
Presenting pain symptomsa | |||
Pelvic muscle spasms (n=4) | 1 (4.8) | 3 (10.3) | 0.63 |
Dyspareunia (n=17) | 7 (33.3) | 10 (34.5) | 1.00 |
Suprapubic pain (n=5) | 4 (19.1) | 1 (3.5) | 0.15 |
Coccyx pain (n=2) | 2 (9.5) | 0 (0) | 0.17 |
Rectal pain (n=2) | 1 (4.8) | 1 (3.5) | 1.00 |
Severity of symptoms | 6.9±1.7 | 6.6±2.5 | 0.74 |
Months with symptoms | 24 (2–84) | 24 (3–120) | 0.72 |
Menopausal status | |||
Premenopausal (n=25) | 9 (42.9) | 16 (55.2) | 0.57 |
Postmenopausal (n=25) | 12 (57.1) | 13 (44.8) | 0.57 |
Past medical history | |||
Hypertension (n=14) | 5 (23.8) | 9 (31.0) | 0.75 |
Diabetes (n=3) | 1 (4.8) | 2 (6.9) | 1.00 |
Adenomyosis/fibroids (n=2) | 0 (0) | 2 (6.9) | 0.50 |
Endometriosis (n=6) | 3 (14.3) | 3 (10.3) | 0.69 |
Chronic bowel diseaseb (n=7) | 6 (28.6) | 1 (3.5) | 0.03 |
Prior pelvic floor surgery | |||
None (n=35) | 17 (81.0) | 18 (62.1) | 0.22 |
Interstim (n=3) | 1 (4.8) | 2 (6.9) | 1.00 |
Apical suspension (n=5) | 1 (4.8) | 4 (13.8) | 0.38 |
Incontinence sling (n=6) | 0 (0) | 6 (20.7) | 0.03 |
Vaginal meshc (n=7) | 1 (4.8) | 6 (20.7) | 0.22 |
Values are presented as number (%), mean±standard deviation, or median (range).
a:In addition to generalized pelvic pain. b:Chronic bowel disease includes irritable bowel syndrome, inflammatory bowel disease, and diverticulosis. c:Vaginal mesh includes those used for anterior/posterior repair with/without placement of a concomitant incontinence sling.